GENOVA, Inc. (TYO:9341)
Japan · Delayed Price · Currency is JPY 747.00
+7.00 (0.95%)
Aug 7, 2025, 2:36 PM JST
Revance Therapeutics Market Cap
GENOVA has a market cap or net worth of 12.81 billion as of August 6, 2025. Its market cap has decreased by -55.71% in one year.
Market Cap
12.81B
Enterprise Value
6.96B
Revenue
10.01B
Ranking
n/a
PE Ratio
9.36
Stock Price
$747.00
Market Cap Chart
Since December 23, 2022, GENOVA's market cap has decreased from 29.37B to 12.81B, a decrease of -56.39%. That is a compound annual growth rate of -27.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 12.81B | -45.15% |
| Dec 30, 2024 | 23.35B | -18.65% |
| Dec 29, 2023 | 28.70B | 1.47% |
| Dec 30, 2022 | 28.29B | -3.68% |
| Dec 23, 2022 | 29.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.20T |
| Daiichi Sankyo Company | 6,770.75B |
| Takeda Pharmaceutical Company | 6,621.29B |
| HOYA Corporation | 6,402.73B |
| Otsuka Holdings | 3,996.90B |
| Terumo | 3,777.61B |
| Astellas Pharma | 2,852.86B |
| Shionogi & | 2,235.01B |